The Mevalonate Pathway: Innovations, Applications, and Challenges in Biotechnology with Emphasis on Fungal Biology
Journal of Fungi · 07.07.2026 · 12 (7) · 497
DOI: 10.3390/jof12070497 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Fungi, online erschienen am 07.07.2026. Verfasst von Aisel Valle Garay und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biophysics, Department of Cell Biology, Institute of Biological Sciences, University of Brasília (UnB), Asa Norte, Brasília-D…. Die Arbeit nennt 367 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Research Support of the Federal District, National Council for Scientific and Technological Development, Institutos Nacionais de Ciência e Tecnologia.
Abstract (Originalsprache)
The mevalonate (MVA) pathway is a central metabolic route responsible for the biosynthesis of isoprenoids with broad biological and biotechnological relevance. Due to its importance, the MVA pathway has attracted increasing interest in studies of enzymatic regulation, structural biology, metabolic engineering, and synthetic biology, particularly in fungi. This review provides a comprehensive overview of the MVA pathway, addressing its distribution across different domains of life, evolutionary aspects, and metabolic organization, with emphasis in fungi. Special attention is given to the biochemical and structural characterization of MVA-pathway enzymes, including catalytic mechanisms, structural features, and regulatory processes. The methylerythritol phosphate pathway is also presented as an alternative route for isoprenoid precursor biosynthesis and discussed in terms of its taxonomic distribution and metabolic significance. Recent advances in synthetic biology, enzyme regulation, and pathway engineering are highlighted, emphasizing their contributions to metabolic engineering and synthetic biology. Special emphasis is given to fungi, in which the MVA pathway plays a central role in ergosterol biosynthesis, protein prenylation, and secondary metabolite production. Advances in the engineering of fungal cells, including Saccharomyces cerevisiae and other emerging fungal species, are discussed in the context of sustainable isoprenoid production. Finally, strategies for optimizing microbial production are presented, highlighting the importance of fungal synthetic biology in advancing biotechnological applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Molecular Biophysics, Department of Cell Biology, Institute of Biological Sciences, University of Brasília (UnB), Asa Norte, Brasília-DF 70910-900, Brazil.
- Laboratory of Biocatalyst and Bioprocess Engineering, Department of Cell Biology, Institute of Biological Sciences, University of Brasília (UnB), Asa Norte, Brasília-DF 70910-900, Brazil.
- Laboratory of Synthetic Biology, Center for Molecular Biotechnology (C-Biotech), University of Brasília Science and Technology Park (PCTec), Asa Norte, Brasília-DF 70910-900, Brazil.
- Department of Genetics and Morphology, Institute of Biological Science, University of Brasília (UnB), Asa Norte, Brasília-DF 70910-900, Brazil.
- Microbial Genetics and Biotechnology Laboratory, EMBRAPA Agroenergy, Parque Estação Biológica (PqEB), Ave. W3 Norte (Final), s/n, Edifício da EMBRAPA Agroenergia, Brasília-DF 70770-901, Brazil.
- Pharmacy Department, Faculty of Health, University of Brasília (UnB), Asa Norte, Brasília-DF 70910-900, Brazil.
ORCID-Profile: Cíntia Marques Coelho, Matheus de Castro Leitão, Luiza Cesca Piva, Janice Lisboa De Marco, Izadora Cristina Moreira de Oliveira, Matheus Ferroni Schwartz, Túlio Marcos Godoy de Andrade, Talita Souza Carmo, João Ricardo Moreira de Almeida, Fernando Araripe Gonçalves Torres, Sonia Maria de Freitas
Förderung
- Foundation for Research Support of the Federal District
- National Council for Scientific and Technological Development
- Institutos Nacionais de Ciência e Tecnologia
Zitieren
APA
Valle Garay, A., Marques Coelho, C., Fonseca Valadares, N., Ferreira da Silva, L., Sousa Cabral, L., de Castro Leitão, M., Piva, L. C., Lisboa De Marco, J., Rabello de Camargo, B., Araújo Souza, A., Moreira de Oliveira, I. C., Schwartz, M. F., Godoy de Andrade, T. M., Souza Carmo, T., Moreira de Almeida, J. R., Gonçalves Torres, F. A., & de Freitas, S. M. (2026). The Mevalonate Pathway: Innovations, Applications, and Challenges in Biotechnology with Emphasis on Fungal Biology. Journal of Fungi, 12(7), 497. https://doi.org/10.3390/jof12070497
Vancouver
Valle Garay A, Marques Coelho C, Fonseca Valadares N, Ferreira da Silva L, Sousa Cabral L, de Castro Leitão M, et al. The Mevalonate Pathway: Innovations, Applications, and Challenges in Biotechnology with Emphasis on Fungal Biology. Journal of Fungi. 2026;12(7):497. doi:10.3390/jof12070497
BibTeX
@article{ValleGaray2026,
author = {Valle Garay, Aisel and Marques Coelho, Cíntia and Fonseca Valadares, Napoleão and Ferreira da Silva, Leonardo and Sousa Cabral, Letícia and de Castro Leitão, Matheus and Piva, Luiza Cesca and Lisboa De Marco, Janice and Rabello de Camargo, Brenda and Araújo Souza, Amanda and Moreira de Oliveira, Izadora Cristina and Schwartz, Matheus Ferroni and Godoy de Andrade, Túlio Marcos and Souza Carmo, Talita and Moreira de Almeida, João Ricardo and Gonçalves Torres, Fernando Araripe and de Freitas, Sonia Maria},
title = {The Mevalonate Pathway: Innovations, Applications, and Challenges in Biotechnology with Emphasis on Fungal Biology},
journal = {Journal of Fungi},
year = {2026},
volume = {12},
number = {7},
pages = {497},
doi = {10.3390/jof12070497}
}
EUVIMED